Registered entities
Serina Therapeutics, Inc.
Reg. No. 20-5757299United States
Innovation
13 patent families (10 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 1,125 times.
| Year | Filings |
|---|---|
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 1 |
Social engagement
Social engagement: 1.8K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |
Recent activity
4 May 2026
Product launch
SER-252
20 Feb 2026
Milestone
regulatory
19 Feb 2026
Milestone
regulatory